Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature.
<h4>Background</h4>Aripiprazole, a second-generation antipsychotic medication, has been increasingly used in the maintenance treatment of bipolar disorder and received approval from the U.S. Food and Drug Administration for this indication in 2005. Given its widespread use, we sought to...
Guardado en:
Autores principales: | Alexander C Tsai, Nicholas Z Rosenlicht, Jon N Jureidini, Peter I Parry, Glen I Spielmans, David Healy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b3dc15b84c7041949d2650b0815a12cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
por: McIntyre R, et al.
Publicado: (2011) -
Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes.
por: Glen I Spielmans, et al.
Publicado: (2013) -
Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients
por: Torres-Llenza V, et al.
Publicado: (2018) -
Use of the Functioning Assessment Short Test (FAST) in defining functional recovery in bipolar I disorder. Post-hoc analyses of long-term studies of aripiprazole once monthly as maintenance treatment
por: Madera J, et al.
Publicado: (2019) -
Treatment and prevention of mania in bipolar&nbsp;I disorder: focus on aripiprazole
por: David J Muzina
Publicado: (2009)